Kardigan, Inc. (KARD)Healthcare | Biotechnology | Princeton, United States | NasdaqGM
13.52 USD
+0.55
(4.241%)
⇧
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 13.52 |
Hot Take ↕ | Oct. 10, 2026, 3:37 a.m. EDT
The investment case here is fundamentally broken by the company's financial reality. As a biotechnology firm, Kardigan is burning significant cash, evidenced by negative operating cash flow of roughly $206 million and negative earnings per share of -$11.02. The forward P/E is negative, confirming that analysts cannot project profitability in the near term. While the balance sheet shows a massive current ratio of 8.7x due to high cash reserves, this liquidity is likely intended to fund the upcoming IPO mentioned in recent headlines rather than sustain operations indefinitely without dilution. The stock has underperformed significantly, trading well below its 50-day and 200-day moving averages, reflecting a market that has priced out the current business model. With no dividend to provide income and a statistical forecast model predicting a further decline over the next 45 days, there is no immediate catalyst to reverse the downtrend. The recent news of an IPO suggests the current public float may soon be diluted or replaced, adding uncertainty to the current price structure. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.103960 |
| MSTL | 0.130849 |
| AutoETS | 0.131154 |
| AutoARIMA | 0.132151 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 12.91 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.077 |
| Excess Kurtosis | -1.07 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.168 |
| Market Cap | 1,264,169,984 |
| Forward P/E | -4.64 |
| Website | https://www.kardigan.bio |
As of Oct. 10, 2026, 3:37 a.m. EDT: Speculator positioning is negligible and non-directional. Call volume and open interest are extremely thin across expirations, with no meaningful concentration at strikes other than the ATM anchor. Put activity is virtually absent, indicating a lack of hedging or bearish bets. Implied volatility is elevated relative to standard equity levels (3.19% for the nearest put), suggesting some fear premium, but the lack of actual option flow confirms this is not driven by active speculative positioning.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.41045457 |
| Address1 | 506 Carnegie Center Drive |
| Address2 | Suite 201 |
| All Time High | 27.0 |
| All Time Low | 12.23 |
| Ask | 21.4 |
| Ask Size | 1 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 679,500 |
| Average Daily Volume3 Month | 495,500 |
| Average Volume | 495,500 |
| Average Volume10Days | 679,500 |
| Bid | 20.94 |
| Bid Size | 1 |
| Book Value | 6.585 |
| City | Princeton |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 13.52 |
| Current Ratio | 8.716 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 13.6 |
| Day Low | 12.34 |
| Debt To Equity | 2.168 |
| Display Name | Kardigan |
| Dividend Yield | 0.0 |
| Earnings Timestamp | 1,786,451,400 |
| Earnings Timestamp End | 1,794,227,400 |
| Earnings Timestamp Start | 1,794,227,400 |
| Ebitda | -265,676,992 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -2.559 |
| Enterprise Value | 679,921,984 |
| Eps Current Year | -4.29774 |
| Eps Forward | -2.9109 |
| Eps Trailing Twelve Months | -11.13 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 18.3056 |
| Fifty Day Average Change | -4.7855988 |
| Fifty Day Average Change Percent | -0.26142815 |
| Fifty Two Week Change Percent | -41.045456 |
| Fifty Two Week High | 27.0 |
| Fifty Two Week High Change | -13.48 |
| Fifty Two Week High Change Percent | -0.49925923 |
| Fifty Two Week Low | 12.23 |
| Fifty Two Week Low Change | 1.2900009 |
| Fifty Two Week Low Change Percent | 0.10547841 |
| Fifty Two Week Range | 12.23 - 27.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,781,789,400,000 |
| Float Shares | 51,758,973 |
| Forward Eps | -2.9109 |
| Forward P E | -4.644612 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 241 |
| Fullday Change | 0.5500002 |
| Fullday Change Percent | 4.2405567 |
| Fullday Price | 13.52 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.15583 |
| Held Percent Institutions | 0.78309995 |
| Implied Shares Outstanding | 93,503,699 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-06-18 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking. The company incorporates Prolaio's cardiovascular data collection and analytics platform, which includes FDA-cleared algorithms and high-density patient data, to support drug development and clinical intelligence. The company engages in strategic in-licensing and acquisitions to expand its pipeline of targeted treatments. Kardigan serves biopharmaceutical companies, cardiovascular researchers, and healthcare providers in the cardiology sector. The company was formerly known as EnCarda, Inc. and changed its name to Kardigan, Inc. in December 2024. The company was founded in 2023 and is based in Princeton, New Jersey. |
| Long Name | Kardigan, Inc. |
| Market | us_market |
| Market Cap | 1,264,169,984 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1916374431 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -288,784,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,357,673,709 |
| Number Of Analyst Opinions | 5 |
| Open | 12.53 |
| Operating Cashflow | -205,608,000 |
| Operating Margins | 0.0 |
| Phone | (415) 573-3220 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 13.52 |
| Post Market Time | 1,792,008,069 |
| Previous Close | 12.97 |
| Price Eps Current Year | -3.1458395 |
| Price Hint | 2 |
| Price To Book | 2.0531511 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.537 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.2 |
| Region | US |
| Regular Market Change | 0.55 |
| Regular Market Change Percent | 4.24056 |
| Regular Market Day High | 13.6 |
| Regular Market Day Low | 12.34 |
| Regular Market Day Range | 12.34 - 13.6 |
| Regular Market Open | 12.53 |
| Regular Market Previous Close | 12.97 |
| Regular Market Price | 13.52 |
| Regular Market Time | 1,792,008,001 |
| Regular Market Volume | 826,675 |
| Sand P52 Week Change | 0.1570785 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 93,503,699 |
| Shares Percent Shares Out | 0.0475 |
| Shares Short | 4,445,126 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 2,208,292 |
| Short Name | Kardigan, Inc. |
| Short Percent Of Float | 0.0557 |
| Short Ratio | 5.62 |
| Source Interval | 15 |
| State | NJ |
| Symbol | KARD |
| Target High Price | 46.0 |
| Target Low Price | 25.0 |
| Target Mean Price | 38.8 |
| Target Median Price | 40.0 |
| Total Cash | 597,595,008 |
| Total Cash Per Share | 6.391 |
| Total Debt | 13,347,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -11.13 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 19.880865 |
| Two Hundred Day Average Change | -6.3608646 |
| Two Hundred Day Average Change Percent | -0.3199491 |
| Type Disp | Equity |
| Volume | 826,675 |
| Website | https://www.kardigan.bio |
| Zip | 8,540 |